Kirtane, Kedar

Racial and ethnic disparities in hematologic malignancies

Kirtane, K., & Lee, S. J. (2017) · Blood

Global Cancer Incidence and ScreeningHealth disparities and outcomes

Cited by 168

T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study

Gainor, J. F., Patel, M. R., Weber, J. S., Gutierrez, M., Bauman, J. E., Clarke, J. M., Julian, R., Scott, A. J., Geiger, J. L., Kirtane, K., et al. (2024) · Cancer Discovery

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 124

Psychosocial characteristics of patients undergoing cellular immunotherapies and their caregivers across time

Kirtane, K., Reblin, M., Oswald, L. B., Irizarry-Arroyo, N., McCormick, R., Locke, F. L., & Ketcher, D. (2023) · Leukemia & Lymphoma

Cancer survivorship and careCAR-T cell therapy research

Cited by 6